Evogene Ltd. EVGN
NASDAQ
| 06/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -72.48% | -72.48% | -705.85% | ||
| Total Depreciation and Amortization | -20.97% | -6.45% | -29.71% | ||
| Total Amortization of Deferred Charges | 1.23% | 1.23% | -2.40% | ||
| Total Other Non-Cash Items | 131.55% | 133.68% | 69.30% | ||
| Change in Net Operating Assets | 167.34% | 162.29% | -300.76% | ||
| Cash from Operations | 55.60% | 55.60% | -13.62% | ||
| Capital Expenditure | 98.35% | 98.35% | 62.42% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 57.53% | 57.53% | -125.59% | ||
| Cash from Investing | 59.55% | 59.55% | -127.92% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 25.34% | 6.16% | 52.90% | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -92.31% | 123.08% | -112.50% | ||
| Cash from Financing | 2,709.43% | 2,709.43% | 22.82% | ||
| Foreign Exchange rate Adjustments | 325.00% | 325.00% | -185.71% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 110.68% | 110.68% | -295.93% | ||